{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:25:53Z","timestamp":1791339953656,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08845-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:24:04Z","timestamp":1751397844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Survival benefits of primary tumor resection in metastatic differentiated thyroid cancer: an analysis of SEER data"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiaqiang","family":"Dan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"8845_CR1","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"10061","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas, M. E., McFadden, D. G. & Durante, C. Thyroid Cancer. Lancet 10061, 2783\u20132795 (2016).","journal-title":"Lancet"},{"key":"8845_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"1","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid 1, 1\u2013133 (2016).","journal-title":"Thyroid"},{"key":"8845_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.4158\/EP171924.OR","volume":"10","author":"D Hirsch","year":"2017","unstructured":"Hirsch, D. et al. Long-Term outcomes and prognostic factors in patients with differentiated thyroid Cancer and distant metastases. Endocr. Pract. 10, 1193\u20131200 (2017).","journal-title":"Endocr. Pract."},{"key":"8845_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1590\/2359-3997000000261","volume":"3","author":"A Leite","year":"2017","unstructured":"Leite, A. et al. Deaths related to differentiated thyroid cancer: A rare but real event. Arch. Endocrin Metab. 3, 222\u2013227 (2017).","journal-title":"Arch. Endocrin Metab."},{"key":"8845_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cen.13489","volume":"2","author":"SY Sohn","year":"2018","unstructured":"Sohn, S. Y. et al. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during Long-Term Follow-Up. Clin. Endocrinol. 2, 318\u2013326 (2018).","journal-title":"Clin. Endocrinol."},{"key":"8845_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/SLA.0b013e3181b7faf6","volume":"1","author":"J Lee","year":"2010","unstructured":"Lee, J. & Soh, E. Y. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann. Surg. 1, 114\u2013119 (2010).","journal-title":"Ann. Surg."},{"key":"8845_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2265.2005.02304.x","volume":"1","author":"M Haq","year":"2005","unstructured":"Haq, M. & Harmer, C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin. Endocrinol. 1, 87\u201393 (2005).","journal-title":"Clin. Endocrinol."},{"key":"8845_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/hed.26987","volume":"4","author":"HG Vuong","year":"2022","unstructured":"Vuong, H. G., Le, M. K., Hassell, L., Kondo, T. & Kakudo, K. The differences in distant metastatic patterns and their corresponding survival between thyroid Cancer subtypes. Head Neck-J Sci. Spec. 4, 926\u2013932 (2022).","journal-title":"Head Neck-J Sci. Spec."},{"key":"8845_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00384-023-04469-8","volume":"1","author":"N Leone","year":"2023","unstructured":"Leone, N. et al. Colorectal Cancer with synchronous unresectable liver metastases: resecting the primary tumor improves survival. Int. J. Colorectal Dis. 1, 169 (2023).","journal-title":"Int. J. Colorectal Dis."},{"key":"8845_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/tbj.13005","volume":"4","author":"NA Vohra","year":"2018","unstructured":"Vohra, N. A., Brinkley, J., Kachare, S. & Muzaffar, M. Primary tumor resection in metastatic breast cancer: A Propensity-Matched analysis, 1988\u20132011 SEER data base. Breast J. 4, 549\u2013554 (2018).","journal-title":"Breast J."},{"key":"8845_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/XCS.0000000000001035","volume":"6","author":"JH Rodriguez-Quintero","year":"2024","unstructured":"Rodriguez-Quintero, J. H. et al. Resection of the primary tumor and survival in patients with Single-Site synchronous oligometastatic Non-Small cell lung cancer: Propensity-Matched analysis of the National Cancer database. J. Am. Coll. Surg. 6, 1122\u20131136 (2024).","journal-title":"J. Am. Coll. Surg."},{"key":"8845_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1072-7515(03)00332-6","volume":"2","author":"M Shoup","year":"2003","unstructured":"Shoup, M. et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J. Am. Coll. Surg. 2, 191\u2013197 (2003).","journal-title":"J. Am. Coll. Surg."},{"key":"8845_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2010.0353","volume":"7","author":"K Sugino","year":"2011","unstructured":"Sugino, K. et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 7, 751\u2013757 (2011).","journal-title":"Thyroid"},{"key":"8845_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.surg.2007.06.011","volume":"1","author":"I Sugitani","year":"2008","unstructured":"Sugitani, I., Fujimoto, Y. & Yamamoto, N. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 1, 35\u201342 (2008).","journal-title":"Surgery"},{"key":"8845_CR15","doi-asserted-by":"crossref","unstructured":"Shi, X. et al. Prognostic significance and optimal candidates of primary tumor resection in major salivary gland carcinoma patients with distant metastases at initial presentation: A Population-Based study. Oral Oncol. 78, 87\u201393 (2018).","DOI":"10.1016\/j.oraloncology.2018.01.009"},{"key":"8845_CR16","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ejso.2018.08.002","volume":"10","author":"W Xiao","year":"2018","unstructured":"Xiao, W. et al. Primary tumor resection in stage IV breast cancer: A systematic review and Meta-Analysis. Ejso-Eur J. Surg. Onc. 10, 1504\u20131512 (2018).","journal-title":"Ejso-Eur J. Surg. Onc"},{"key":"8845_CR17","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1002\/cam4.2431","volume":"11","author":"M Zheng","year":"2019","unstructured":"Zheng, M., Li, Y., Li, T., Zhang, L. & Zhou, L. Resection of the primary tumor improves survival in patients with Gastro-Entero-Pancreatic neuroendocrine neoplasms with liver metastases: A SEER-Based analysis. Cancer Med-Us. 11, 5128\u20135136 (2019).","journal-title":"Cancer Med-Us"},{"key":"8845_CR18","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1089\/thy.2014.0173","volume":"11","author":"LY Wang","year":"2014","unstructured":"Wang, L. Y. et al. Multi-Organ distant metastases confer worse Disease-Specific survival in differentiated thyroid Cancer. Thyroid 11, 1594\u20131599 (2014).","journal-title":"Thyroid"},{"key":"8845_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1089\/thy.2022.0061","volume":"9","author":"MS Brose","year":"2022","unstructured":"Brose, M. S. et al. Multikinase inhibitors for the treatment of asymptomatic radioactive Iodine-Refractory differentiated thyroid cancer: global noninterventional study (RIFTOS MKI). Thyroid 9, 1059\u20131068 (2022).","journal-title":"Thyroid"},{"key":"8845_CR20","doi-asserted-by":"crossref","unstructured":"Jing, R. et al. Efficacy and safety of multikinase inhibitors for patients with refractory thyroid cancer: systematic review and network Meta-Analysis. J Clin. Endocr. Metab. 109(10), 2658\u20132672 (2024).","DOI":"10.1210\/clinem\/dgae454"},{"key":"8845_CR21","doi-asserted-by":"crossref","unstructured":"Shen, H. et al. Radioiodine-Refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resist. Update 72, 101013 (2024).","DOI":"10.1016\/j.drup.2023.101013"},{"key":"8845_CR22","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jcem.84.11.6115","volume":"11","author":"Y Kitamura","year":"1999","unstructured":"Kitamura, Y. et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J. Clin. Endocr. Metab. 11, 4043\u20134049 (1999).","journal-title":"J. Clin. Endocr. Metab."},{"key":"8845_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/00005537-200106000-00011","volume":"6","author":"NJ Beasley","year":"2001","unstructured":"Beasley, N. J., Walfish, P. G., Witterick, I. & Freeman, J. L. Cause of death in patients with Well-Differentiated thyroid carcinoma. Laryngoscope 6, 989\u2013991 (2001).","journal-title":"Laryngoscope"},{"key":"8845_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10549-015-3636-4","volume":"3","author":"Z Mu","year":"2015","unstructured":"Mu, Z. et al. Prospective assessment of the prognostic value of Circulating tumor cells and their clusters in patients with Advanced-Stage breast Cancer. Breast Cancer Res. Tr. 3, 563\u2013571 (2015).","journal-title":"Breast Cancer Res. Tr."},{"key":"8845_CR25","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1158\/1078-0432.CCR-05-1769","volume":"21","author":"GT Budd","year":"2006","unstructured":"Budd, G. T. et al. Circulating tumor cells versus Imaging\u2013Predicting overall survival in metastatic breast Cancer. Clin. Cancer Res. 21, 6403\u20136409 (2006).","journal-title":"Clin. Cancer Res."},{"key":"8845_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1463-1318.2011.02817.x","volume":"8","author":"S Anwar","year":"2012","unstructured":"Anwar, S., Peter, M. B., Dent, J. & Scott, N. A. Palliative excisional surgery for primary colorectal Cancer in patients with incurable metastatic disease. Is there a survival benefit?? A systematic review. Colorectal Dis. 8, 920\u2013930 (2012).","journal-title":"Colorectal Dis."},{"key":"8845_CR27","doi-asserted-by":"crossref","unstructured":"Kim, M. S. et al. Prognostic factors predicting survival in incurable stage IV colorectal Cancer patients who underwent palliative primary tumor resection. Retrospective cohort study. Int. J. Surg. 49, 10\u201315 (2018).","DOI":"10.1016\/j.ijsu.2017.11.038"},{"key":"8845_CR28","doi-asserted-by":"crossref","unstructured":"Yoo, J., Kim, H. J., Kim, S. M. & Park, H. H. Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid Cancer. Eur. Thyroid J. 11(5) (2022).","DOI":"10.1530\/ETJ-22-0087"},{"key":"8845_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00268-016-3405-5","volume":"3","author":"F Saito","year":"2016","unstructured":"Saito, F. et al. Prognosis after brain metastasis from differentiated thyroid carcinoma. World J. Surg. 3, 574\u2013581 (2016).","journal-title":"World J. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:24:06Z","timestamp":1751397846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08845-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol for this study was approved by the Ethics Committee of Chengdu Fifth People\u2019s Hospital (The Second Clincal Medical College, Affiliated Fifth People\u2019s Hospital of Chengdu University of Traditional Chinese Medicine). As the SEER database was publicly accessible, the present study did not require informed patient consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement and consent to participate"}}],"article-number":"21932"}}